Official UK procurement notice
Hepatitis C Medicines · UK public procurement notice
Authority: NHS National Services Scotland (NHS & healthcare)
What is being bought2 lots · detail below
Published requirement descriptionThe framework agreement is awarded for the supply of medicines used to treat Hepatitis C to NHS Scotland.
CPV: Pharmaceutical products
Lots and requirements (2)Procurement structure
2 lots · no lot values publishedLot #1Treatment Cost per Medicine
This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHSScotland.
Lot #2Treatment Spend Cap
This Framework Agreement is for the supply of branded medicines under a capped spend model used in the treatment of Hepatitis C to NHSScotland.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 7 Feb 2022, 09:55 GMT
- Last source update
- 7 Feb 2022, 09:55 GMT
- Authority reference
NP49119- FTS notice number
2022/S 000-003365- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0313c0Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
Publisher note: The estimated value(s) referred to in Section II.I.7 and both Lots covers the twelve (12) month modification period of the framework agreement. (SC Ref:682305)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Treatment Cost per Medicine
- Signed
- 7 Feb 2022
- Value
- £3,500,000
- Status
- active
Treatment Spend Cap
- Signed
- 7 Feb 2022
- Value
- £4,000,000
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
3 commercial parties on the notice- AbbVie LtdFramework contractor
- Gilead Sciences LtdFramework contractor
- Merck Sharp & Dohme UK LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.